NCT02387580 Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets Status COMPLETED Phase PHASE1
NCT02374580 Partnership and Dignity: a Mixed-methods Survey on Supporting and Retaining Uganda's Village Health Teams Status COMPLETED Phase N/A
NCT02374450 A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine Status COMPLETED Phase N/A
NCT02334462 Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali Status COMPLETED Phase PHASE1
NCT02329301 Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia Status COMPLETED Phase NA
NCT02315690 Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland Status COMPLETED Phase PHASE3
NCT02313376 Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes Status COMPLETED Phase PHASE1
NCT02297477 The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia Status UNKNOWN Phase PHASE4
NCT02294214 Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Tanzania Status WITHDRAWN Phase NA
NCT02294201 Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya Status WITHDRAWN Phase NA
NCT02294188 Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia Status COMPLETED Phase NA
NCT02288637 Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product Status COMPLETED Phase NA
NCT02282293 Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) Status COMPLETED Phase PHASE3
NCT02259426 Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission Status COMPLETED Phase PHASE3
NCT02251704 Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa Status COMPLETED Phase PHASE4
NCT02242799 Dolutegravir Interactions With Artemisinin-based Combination Therapies Status COMPLETED Phase PHASE1
NCT02237586 Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge Status COMPLETED Phase PHASE1
NCT02230579 Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02215707 A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses Status COMPLETED Phase PHASE1